Concurrent chemoradiotherapy with or without simultaneous integrated boost for unresectable stage III non-small-cell lung cancer: a randomized phase II trial with exploratory EGFR and PD-L1 analyses

Cancer Genetics · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles